GUJARAT THEMIS BIOSYN
Back to Cashflow Statement
|
GUJARAT THEMIS BIOSYN Last 5 Year Cash Flow from Operating Activities History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹40 Cr | ₹40 Cr | ₹11 Cr | ₹0.63 Cr | ₹0.69 Cr |
What is the latest Cash Flow from Operating Activities ratio of GUJARAT THEMIS BIOSYN ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2023 | ₹40 Cr |
Mar2022 | ₹40 Cr |
Mar2021 | ₹11 Cr |
Mar2020 | ₹0.63 Cr |
Mar2019 | ₹0.69 Cr |
How is Cash Flow from Operating Activities of GUJARAT THEMIS BIOSYN Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2023 | ₹40 Cr | -2.01 | |
Mar2022 | ₹40 Cr | 282.80 | |
Mar2021 | ₹11 Cr | 1,568.94 | |
Mar2020 | ₹0.63 Cr | -8.02 | |
Mar2019 | ₹0.69 Cr | - |
Compare Cash Flow from Operating Activities of peers of GUJARAT THEMIS BIOSYN
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GUJARAT THEMIS BIOSYN | ₹2,939.6 Cr | -0.9% | 5.2% | 176.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹361,916.0 Cr | 0.3% | -7.5% | 53.9% | Stock Analytics | |
CIPLA | ₹115,034.0 Cr | 1.1% | -4.8% | 56.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,929.0 Cr | 1.6% | 1.6% | 27.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,873.0 Cr | -1.9% | 10.7% | 21.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,322.0 Cr | 5.2% | -0.2% | 90.1% | Stock Analytics |
GUJARAT THEMIS BIOSYN Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GUJARAT THEMIS BIOSYN | -0.9% |
5.2% |
176.7% |
SENSEX | -0.6% |
0.3% |
21.8% |
You may also like the below Video Courses